Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Rozelle Harvie"'
Autor:
Yaser H. Gholami, Kathy P. Willowson, Nicholas J. Forwood, Rozelle Harvie, Nicholas Hardcastle, Regina Bromley, HyunJu Ryu, Samuel Yuen, Viive M. Howell, Zdenka Kuncic, Dale L. Bailey
Publikováno v:
EJNMMI Physics, Vol 5, Iss 1, Pp 1-19 (2018)
Abstract Background Dose rate variation is a critical factor affecting radionuclide therapy (RNT) efficacy. Relatively few studies to date have investigated the dose rate effect in RNT. Therefore, the aim of this study was to benchmark 90Y RNT (at di
Externí odkaz:
https://doaj.org/article/b1d4ba62997a4d26966e1c47ee59dd6c
Autor:
Yaowu He, Csilla Hasovits, Amanda L. Hudson, Rozelle Harvie, Viive M. Howell, Katherine B. Sahin, Priyakshi Kalita-de Croft, Christopher Molloy, Sunil R. Lakhani, Sarah A. Hayes, Hannah Kamitakahara, Tashbib Khan, Genevieve P. Ferguson, Derek J. Richard, Kenneth J. O'Byrne, Esha T. Shah, Emma Bolderson, Mark N. Adams, Emily Colvin, Pascal H.G. Duijf, John D. Hooper
Publikováno v:
Cancers
Cancers, Vol 13, Iss 4651, p 4651 (2021)
Volume 13
Issue 18
Cancers, Vol 13, Iss 4651, p 4651 (2021)
Volume 13
Issue 18
Simple Summary Resistance to tyrosine kinase inhibitors (TKIs) that target common non-small-cell lung cancer mutations within the epidermal growth factor receptor (EGFR) is a primary clinical issue. The aim of our study was to determine whether the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2d143bd6bdc2dce4e41407c1d4df887
https://doi.org/10.3390/cancers13184651
https://doi.org/10.3390/cancers13184651
Autor:
Kathy Willowson, Nicholas Hardcastle, Viive M. Howell, Dale L. Bailey, Nicholas Forwood, Samuel Yuen, Yaser Hadi Gholami, Rozelle Harvie, Zdenka Kuncic, Regina Bromley, HyunJu Ryu
Publikováno v:
EJNMMI Physics, Vol 5, Iss 1, Pp 1-19 (2018)
Dose rate variation is a critical factor affecting radionuclide therapy (RNT) efficacy. Relatively few studies to date have investigated the dose rate effect in RNT. Therefore, the aim of this study was to benchmark 90Y RNT (at different dose rates)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21a5f3519a61fd330e81b16563126dc3
https://doi.org/10.1186/s40658-018-0217-8
https://doi.org/10.1186/s40658-018-0217-8
Autor:
Amanda L. Hudson, Sarah A. Hayes, Stephen Clarke, Viive M. Howell, Nick Pavlakis, Malinda Itchins, Rozelle Harvie, G.H. Wei, Michael E. Buckland
Publikováno v:
Journal of Thoracic Oncology. 14:S413-S414
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efdaac388a1705db0127382cbe0fea57
https://doi.org/10.1016/j.jtho.2019.08.844
https://doi.org/10.1016/j.jtho.2019.08.844
Autor:
Yaser H, Gholami, Kathy P, Willowson, Nicholas J, Forwood, Rozelle, Harvie, Nicholas, Hardcastle, Regina, Bromley, HyunJu, Ryu, Samuel, Yuen, Viive M, Howell, Zdenka, Kuncic, Dale L, Bailey
Publikováno v:
EJNMMI physics. 5(1)
Dose rate variation is a critical factor affecting radionuclide therapy (RNT) efficacy. Relatively few studies to date have investigated the dose rate effect in RNT. Therefore, the aim of this study was to benchmarkThree human colorectal carcinoma (C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bce8da421da4d3d3d909013c196b83a3
https://pubmed.ncbi.nlm.nih.gov/30175390
https://pubmed.ncbi.nlm.nih.gov/30175390
Autor:
Steven Kao, Rozelle Harvie, Stephen Clarke, Rick Abraham, Zoltan Kerestes, Gavin Marx, Robyn Taylor, Nick Pavlakis, Martin Cullen, Ross A. Davey, Florian Paturi
Publikováno v:
Lung Cancer. 75:248-254
There is a need for new treatment strategies and prognostic markers for the management of malignant mesothelioma (MM). The activity of thalidomide/cisplatin/gemcitabine (arm A) or thalidomide alone (arm B) was investigated in two parallel phase II st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70a46c8a141255aa4cacbb5d023f7e56
https://doi.org/10.1016/j.lungcan.2011.06.007
https://doi.org/10.1016/j.lungcan.2011.06.007
Autor:
Nick Pavlakis, Rozelle Harvie, Stephen Clarke, Steven Kao, Michael Boyer, Janette L. Vardy, Nico van Zandwijk
Publikováno v:
Clinical Cancer Research. 16:5805-5813
Purpose: Asbestos-induced chronic inflammation is implicated in the pathogenesis of malignant mesothelioma (MM). We have investigated blood neutrophil-to-lymphocyte ratio (NLR), an index of systemic inflammation, as a prognostic factor in MM patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b21004380f40d982249e845239d5e1ae
https://doi.org/10.1158/1078-0432.ccr-10-2245
https://doi.org/10.1158/1078-0432.ccr-10-2245
Autor:
S. Kao, Michael Millward, Adrian Lee, Malinda Itchins, Viive M. Howell, Nick Pavlakis, Sarah A. Hayes, Rozelle Harvie, Stephen Clarke, Marliese Alexander, Brett G.M. Hughes, Thomas John
Publikováno v:
Journal of Thoracic Oncology. 13:S684
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64e38e3970fec2b8a918624699b0ae1d
https://doi.org/10.1016/j.jtho.2018.08.1104
https://doi.org/10.1016/j.jtho.2018.08.1104
Autor:
S. McCowatt, Gavin Marx, V. Lim, Rozelle Harvie, Craig Underhill, Francis Parnis, Mustafa Khasraw, Nick Pavlakis, P. de Souza, Stephen Begbie, Adam Boyce
Publikováno v:
Annals of Oncology. 21:1302-1307
Background: Docetaxel (Taxotere) improve survival and prostate-specific antigen (PSA) response rates in patients with metastatic castrate-resistant prostate cancer (CRPC). We studied the combination of PI-88, an inhibitor of angiogenesis and heparana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0759e70bf583077326fd1cb48739f0b
https://doi.org/10.1093/annonc/mdp524
https://doi.org/10.1093/annonc/mdp524
Autor:
Amanda L. Hudson, Ian D. Davis, Ray M. Lowenthal, George Kannourakis, Anne Long, Nick Pavlakis, Colleen C. Nelson, David Goldstein, Andrew J. Martin, Ganessan Kichenadasse, Lidija Jovanovic, Jeremy Shapiro, Arun Azad, David Espinoza, Michelle Harrison, Martin R. Stockler, Christopher Steer, Rozelle Harvie, Jennifer F. Thompson, Sonia Yip
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 26(6)
Background We hypothesised that alternating inhibitors of the vascular endothelial growth factor receptor (VEGFR) and mammalian target of rapamycin pathways would delay the development of resistance in advanced renal cell carcinoma (aRCC). Patients a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9a7757086809738a8577b8acc94e4f2
https://pubmed.ncbi.nlm.nih.gov/25701452
https://pubmed.ncbi.nlm.nih.gov/25701452